These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30696332)

  • 1. Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance.
    Wagner E; Löhrs L; Siskind D; Honer WG; Falkai P; Hasan A
    J Psychopharmacol; 2019 Apr; 33(4):423-435. PubMed ID: 30696332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis.
    Siskind DJ; Lee M; Ravindran A; Zhang Q; Ma E; Motamarri B; Kisely S
    Aust N Z J Psychiatry; 2018 Aug; 52(8):751-767. PubMed ID: 29732913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia.
    Chiu YH; Hsu CY; Lu ML; Chen CH
    Curr Pharm Des; 2020; 26(2):218-227. PubMed ID: 31924152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
    Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
    Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation strategies in clozapine-resistant schizophrenia.
    Remington G; Saha A; Chong SA; Shammi C
    CNS Drugs; 2005; 19(10):843-72. PubMed ID: 16185094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
    Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
    Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic augmentation strategies in clozapine resistance--what facts?
    Tranulis C; Mouaffak F; Chouchana L; Stip E; Gourevitch R; Poirier MF; Olié JP; Lôo H; Gourion D
    Clin Neuropharmacol; 2006; 29(1):34-44. PubMed ID: 16518133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis.
    Bartoli F; Crocamo C; Di Brita C; Esposito G; Tabacchi TI; Verrengia E; Clerici M; Carrà G
    J Psychiatr Res; 2019 Jan; 108():24-33. PubMed ID: 30447508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is electroconvulsive therapy effective as augmentation in clozapine-resistant schizophrenia?
    Kittsteiner Manubens L; Lobos Urbina D; Aceituno D
    Medwave; 2016 Oct; 16(Suppl5):e6577. PubMed ID: 27813505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine resistance: augmentation strategies.
    Porcelli S; Balzarro B; Serretti A
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):165-82. PubMed ID: 21906915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
    Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
    Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
    Vayısoğlu S; Anıl Yağcıoğlu E
    Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.
    Tiihonen J; Wahlbeck K; Kiviniemi V
    Schizophr Res; 2009 Apr; 109(1-3):10-4. PubMed ID: 19186030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
    J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and nonpharmacological augmentation treatments for clozapine-resistant schizophrenia: A systematic review and network meta-analysis with normalized entropy assessment.
    Yeh TC; Correll CU; Yang FC; Chen MH; Tseng PT; Hsu CW; Carvalho AF; Stubbs B; Thompson T; Chu CS; Yu CL; Il Shin J; Yang SN; Tu YK; Liang CS
    Asian J Psychiatr; 2023 Jan; 79():103375. PubMed ID: 36470132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation strategies for clozapine resistance: a systematic review and meta-analysis.
    Grover S; Sarkar S; Sahoo S
    Acta Neuropsychiatr; 2023 Apr; 35(2):65-75. PubMed ID: 36380513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.
    Correll CU; Rubio JM; Inczedy-Farkas G; Birnbaum ML; Kane JM; Leucht S
    JAMA Psychiatry; 2017 Jul; 74(7):675-684. PubMed ID: 28514486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.
    Veerman SR; Schulte PF; Begemann MJ; de Haan L
    Pharmacopsychiatry; 2014 Nov; 47(7):231-8. PubMed ID: 25121994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.